However, the limitation of this study is that it did not evaluate the direct association of the apoptosis-mitochondrial dependent pathway or the regulation of the PI3K/Akt/mTOR pathway in apoptosis following CGEtOAc and sorafenib treatment in cancer cells. The gene discussed is MTOR; the disease is cancer.